Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m

Previously, we designed the EuK-based PSMA ligand BQ0413 with an maE<sub>3</sub> chelator for labeling with technetium-99m. It showed efficient tumor targeting, but our preclinical data and preliminary clinical results indicated that the renal excretion levels need to be decreased. We hy...

Full description

Bibliographic Details
Main Authors: Ekaterina Bezverkhniaia, Panagiotis Kanellopoulos, Ulrika Rosenström, Vladimir Tolmachev, Anna Orlova
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/25/7/3615
_version_ 1797212564227096576
author Ekaterina Bezverkhniaia
Panagiotis Kanellopoulos
Ulrika Rosenström
Vladimir Tolmachev
Anna Orlova
author_facet Ekaterina Bezverkhniaia
Panagiotis Kanellopoulos
Ulrika Rosenström
Vladimir Tolmachev
Anna Orlova
author_sort Ekaterina Bezverkhniaia
collection DOAJ
description Previously, we designed the EuK-based PSMA ligand BQ0413 with an maE<sub>3</sub> chelator for labeling with technetium-99m. It showed efficient tumor targeting, but our preclinical data and preliminary clinical results indicated that the renal excretion levels need to be decreased. We hypothesized that this could be achieved by a decrease in the ligand’s total negative charge, achieved by substituting negatively charged glutamate residues in the chelator with glycine. The purpose of this study was to evaluate the tumor targeting and biodistribution of two new PSMA inhibitors, BQ0411 and BQ0412, compared to BQ0413. Conjugates were radiolabeled with Tc-99m and characterized in vitro, using PC3-pip cells, and in vivo, using NMRI and PC3-pip tumor-bearing mice. [<sup>99m</sup>Tc]Tc-BQ0411 and [<sup>99m</sup>Tc]Tc-BQ0412 demonstrated PSMA-specific binding to PC3-pip cells with picomolar affinity. The biodistribution pattern for the new conjugates was characterized by rapid excretion. The tumor uptake for [<sup>99m</sup>Tc]Tc-BQ0411 was 1.6-fold higher compared to [<sup>99m</sup>Tc]Tc-BQ0412 and [<sup>99m</sup>Tc]Tc-BQ0413. [<sup>99m</sup>Tc]Tc-BQ0413 has demonstrated predominantly renal excretion, while the new conjugates underwent both renal and hepatobiliary excretion. In this study, we have demonstrated that in such small targeting ligands as PSMA-binding EuK-based pseudopeptides, the structural blocks that do not participate in binding could have a crucial role in tumor targeting and biodistribution. The presence of a glycine-based coupling linker in BQ0411 and BQ0413 seems to optimize biodistribution. In conclusion, the substitution of amino acids in the chelating sequence is a promising method to alter the biodistribution of [<sup>99m</sup>Tc]Tc-labeled small-molecule PSMA inhibitors. Further improvement of the biodistribution properties of BQ0413 is needed.
first_indexed 2024-04-24T10:44:23Z
format Article
id doaj.art-565782fbe8ae4aa68a27718791984428
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-04-24T10:44:23Z
publishDate 2024-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-565782fbe8ae4aa68a277187919844282024-04-12T13:19:15ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672024-03-01257361510.3390/ijms25073615Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99mEkaterina Bezverkhniaia0Panagiotis Kanellopoulos1Ulrika Rosenström2Vladimir Tolmachev3Anna Orlova4Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, SwedenDepartment of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, SwedenDepartment of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, SwedenDepartment of Immunology, Genetics and Pathology, Uppsala University, 752 37 Uppsala, SwedenDepartment of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, SwedenPreviously, we designed the EuK-based PSMA ligand BQ0413 with an maE<sub>3</sub> chelator for labeling with technetium-99m. It showed efficient tumor targeting, but our preclinical data and preliminary clinical results indicated that the renal excretion levels need to be decreased. We hypothesized that this could be achieved by a decrease in the ligand’s total negative charge, achieved by substituting negatively charged glutamate residues in the chelator with glycine. The purpose of this study was to evaluate the tumor targeting and biodistribution of two new PSMA inhibitors, BQ0411 and BQ0412, compared to BQ0413. Conjugates were radiolabeled with Tc-99m and characterized in vitro, using PC3-pip cells, and in vivo, using NMRI and PC3-pip tumor-bearing mice. [<sup>99m</sup>Tc]Tc-BQ0411 and [<sup>99m</sup>Tc]Tc-BQ0412 demonstrated PSMA-specific binding to PC3-pip cells with picomolar affinity. The biodistribution pattern for the new conjugates was characterized by rapid excretion. The tumor uptake for [<sup>99m</sup>Tc]Tc-BQ0411 was 1.6-fold higher compared to [<sup>99m</sup>Tc]Tc-BQ0412 and [<sup>99m</sup>Tc]Tc-BQ0413. [<sup>99m</sup>Tc]Tc-BQ0413 has demonstrated predominantly renal excretion, while the new conjugates underwent both renal and hepatobiliary excretion. In this study, we have demonstrated that in such small targeting ligands as PSMA-binding EuK-based pseudopeptides, the structural blocks that do not participate in binding could have a crucial role in tumor targeting and biodistribution. The presence of a glycine-based coupling linker in BQ0411 and BQ0413 seems to optimize biodistribution. In conclusion, the substitution of amino acids in the chelating sequence is a promising method to alter the biodistribution of [<sup>99m</sup>Tc]Tc-labeled small-molecule PSMA inhibitors. Further improvement of the biodistribution properties of BQ0413 is needed.https://www.mdpi.com/1422-0067/25/7/3615prostate cancerprostate-specific membrane antigenPSMAtechnetium-99mcoupling linkerBQ0411
spellingShingle Ekaterina Bezverkhniaia
Panagiotis Kanellopoulos
Ulrika Rosenström
Vladimir Tolmachev
Anna Orlova
Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m
International Journal of Molecular Sciences
prostate cancer
prostate-specific membrane antigen
PSMA
technetium-99m
coupling linker
BQ0411
title Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m
title_full Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m
title_fullStr Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m
title_full_unstemmed Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m
title_short Influence of Molecular Design on the Tumor Targeting and Biodistribution of PSMA-Binding Tracers Labeled with Technetium-99m
title_sort influence of molecular design on the tumor targeting and biodistribution of psma binding tracers labeled with technetium 99m
topic prostate cancer
prostate-specific membrane antigen
PSMA
technetium-99m
coupling linker
BQ0411
url https://www.mdpi.com/1422-0067/25/7/3615
work_keys_str_mv AT ekaterinabezverkhniaia influenceofmoleculardesignonthetumortargetingandbiodistributionofpsmabindingtracerslabeledwithtechnetium99m
AT panagiotiskanellopoulos influenceofmoleculardesignonthetumortargetingandbiodistributionofpsmabindingtracerslabeledwithtechnetium99m
AT ulrikarosenstrom influenceofmoleculardesignonthetumortargetingandbiodistributionofpsmabindingtracerslabeledwithtechnetium99m
AT vladimirtolmachev influenceofmoleculardesignonthetumortargetingandbiodistributionofpsmabindingtracerslabeledwithtechnetium99m
AT annaorlova influenceofmoleculardesignonthetumortargetingandbiodistributionofpsmabindingtracerslabeledwithtechnetium99m